News & Blogs

FDA’S LAX METHODOLOGY, PART 2

In my December 10 posting, I discussed how physicians are troubled by the FDA’s lax methodology in conducting clinical trial of drugs and medical devices. In today’s Torts Prof Blog , Bill Childs points out...
Read More

NEWS TO END THE WEEK

In the ever contentious area of TORT REFORM, an Oklahoma senator aims to halve contingency fees   (although his state’s current fee allows up to  50% ). Billion-Dollar Verdicts are a thing of the past, according...
Read More